Novo-Passit, 10 pcs.

Pharmacotherapeutic group

Pharmacological sedative of herbal origin

ATX code: N05CM

Pharmacological action

A combined product whose pharmacological activity is due to its constituent herbal extract components with predominantly sedative (sedative) action and guaifenesin which has anxiolytic (anti-anxiety) effect.

Indications

Psycho-emotional stress, Stress

• neurasthenia and neurotic reactions accompanied by irritability, anxiety, fear, fatigue, absent-mindedness.

• “Manager’s Syndrome” (a state of constant mental tension.)

• Ensomnia (mild forms).

• Headaches caused by nervous tension.

• Migraine.

• Functional disorders of the gastrointestinal tract (dyspeptic syndrome, irritable bowel syndrome).

• As a symptomatic treatment for neurocirculatory dystonia and menopausal syndrome.

• Itchy dermatoses (eczema atopic and seborrheic, urticaria) caused by psychological stress.
  

Active ingredient

Hawthorn flowers and leaves, Hawthorn fruits, Guaifenesin, St. John’s wort herb, Hops, Melissa, Passiflora,

Composition

Composition (per tablet)
Active ingredients:
Novo-Passit extract dry (1:6,5) (obtained from valerian herbs with roots (5 part), melissa herb (2 part), St. John’s Wort herb (5 part), hawthorn leaves and flowers (5 part), Passiflora incarnata herb (1 part), common hops (5 part), black elderflower (2 part)). 157.5 mg; guaifenesin 200.0 mg
Excipients:
silica 2.0 mg, microcrystalline cellulose 96.0 mg, glyceryl tribegenate 10.0 mg, magnesium stearate 10.0 mg, lactose monohydrate up to 800.0 mg
coating:
opadray “AMB 80W31115” green (polyvinyl alcohol 45.52%, titanium dioxide 26.5%, talc 20.0%, soy lecithin 2.0%, xanthan gum 0.48%, quinoline yellow dye 2.5%, iron oxide yellow dye 2.0%, indigo carmine dye 1.0%) 24.0 mg.

How to take, the dosage

Internal, adults and children over 12 years of age:

In the absence of other doctor’s recommendations, the drug should be taken 1 tablet 3 times a day before meals. After consultation with the doctor, it is possible to increase the dose to 2 tablets 3 times a day.

In case of severe fatigue or depression, the morning and daily dose should be reduced to 1/2 tablet per reception in the morning and afternoon, and 1 tablet should be taken in the evening.

The interval between doses should be 4-6 hours. In case of nausea, the drug should be taken with food.

Interaction

When taking Novo-Passit® and other drugs at the same time, their effect can be enhanced or weakened. Before starting taking the drug simultaneously with other medicinal products, it is necessary to consult a doctor.

The drug increases the effect of alcohol and other substances that depress the central nervous system.

Medications used to relax skeletal muscles (central myorelaxation) may increase the risk of side effects of the drug, especially muscle weakness.

The Hypericum extract contained in the drug reduces the effectiveness of hormonal contraception, as well as of medicinal products used mainly after transplantation to reduce the risk of rejection of the transplanted organ or tissue (immunosuppressive drugs), medicinal products for AIDS treatment, cardiovascular diseases, bronchial diseases and prevention of thromboembolism. Therefore, it is necessary to consult a physician before starting Novo-Passit against the background of these drugs.

Special Instructions

Alcoholic beverages should not be consumed during treatment with the drug.

During the use of Novo-Passit, especially in patients with fair skin, avoid exposure to ultraviolet radiation (prolonged exposure to direct sunlight, visiting a solarium).

If symptoms persist or worsen after 7 days of treatment, the physician should be told.

Impact on the ability to drive or operate machinery

When using the drug, one should refrain from performing potentially hazardous activities requiring increased concentration and quick psychomotor reactions (including driving vehicles and operating moving machinery).

Contraindications

Hypersensitivity to the components of the drug, especially to guaifenesin, lactose intolerance, lactase deficiency, glucose-galactose malabsorption, myasthenia gravis, children under 12 years of age.

With caution

Acute gastrointestinal tract diseases, liver disease, alcoholism, brain disease or injury, epilepsy, children over 12 years of age.

Pregnancy and lactation

In pregnancy, the drug is prescribed only with absolute indication, if the expected effect for the mother exceeds the possible risk for the fetus.

If it is necessary to use the drug during breastfeeding, breastfeeding should be stopped.

Side effects

Patients usually tolerate the drug well. However, in rare cases, allergic reactions, exanthema, dizziness, fatigue, drowsiness, mild muscle weakness, gastrointestinal disorders (nausea, vomiting, cramps, heartburn, diarrhea, constipation), reduced concentration may occur, which quickly pass after drug withdrawal.

If any of these side effects worsen, or if you notice any other side effects not listed in the instructions, tell your doctor.

Overdose

Overdose at first is manifested by a feeling of depression and drowsiness.

Later these symptoms may be accompanied by nausea, mild muscle weakness, joint pain, a feeling of heaviness in the stomach. If symptoms of overdose occur, the drug should be discontinued.

Pre-hospital care: gastric lavage.

The treatment is symptomatic.

Physician should be consulted.

Pregnancy use

During pregnancy the drug is prescribed only for absolute indications, if the expected effect for the mother exceeds the possible risk to the fetus.

If it is necessary to use the drug during lactation, breastfeeding should be stopped.